PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
99.52%
Net income growth above 1.5x 1097.HK's 38.24%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-80.68%
Both reduce yoy D&A, with 1097.HK at -4.51%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-100.00%
Negative yoy deferred tax while 1097.HK stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-100.00%
Negative yoy SBC while 1097.HK is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
59.20%
Slight usage while 1097.HK is negative at -1354.67%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
100.00%
AR growth well above 1097.HK's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Some yoy usage while 1097.HK is negative at -591.58%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
91.82%
Some yoy increase while 1097.HK is negative at -83.30%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-309.88%
Both yoy CFO lines are negative, with 1097.HK at -99.10%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
86.91%
CapEx growth well above 1097.HK's 18.58%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-89.12%
Negative yoy acquisition while 1097.HK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-42.89%
Both yoy lines negative, with 1097.HK at -9.66%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-138.13%
We reduce yoy invests while 1097.HK stands at 9.30%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-100.00%
Negative yoy issuance while 1097.HK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.